Searched for: subject%3A%22Frailty%22
(1 - 4 of 4)
document
Kuiper, L.M. (author), Polinder-Bos, Harmke A. (author), Bizzarri, D. (author), Vojinovic, Dina (author), Vallerga, Costanza L. (author), Reinders, M.J.T. (author), Slagboom, P. Eline (author), van den Akker, E.B. (author)
Biological age captures a person's age-related risk of unfavorable outcomes using biophysiological information. Multivariate biological age measures include frailty scores and molecular biomarkers. These measures are often studied in isolation, but here we present a large-scale study comparing them. In 2 prospective cohorts (n = 3 222), we...
journal article 2023
document
van der Kruk, E. (author), Silverman, Anne K. (author), Koizia, Louis (author), Reilly, Peter (author), Fertleman, Michael (author), Bull, Anthony M.J. (author)
The prevention, mitigation and treatment of movement impairments, ideally, requires early diagnosis or identification. As the human movement system has physiological and functional redundancy, movement limitations do not promptly arise at the onset of physical decline. A such, prediction of movement limitations is complex: it is unclear how...
journal article 2021
document
Pazan, Farhad (author), Petrovic, Mirko (author), Cherubini, Antonio (author), Onder, Graziano (author), Cruz-Jentoft, Alfonso J. (author), Denkinger, Michael (author), van der Cammen, T.J.M. (author), Stevenson, Jennifer M. (author), Ibrahim, Kinda (author)
Background: Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated with the severity of frailty; however, a causal relation has not been proven in older people with clinically manifest frailty. Methods: A literature search was performed in Medline to detect prospective randomized controlled trials (RCTs)...
review 2020
document
Cammelbeeck, C.I. (author)
master thesis 2013
Searched for: subject%3A%22Frailty%22
(1 - 4 of 4)